Reports

The global 5-Hydroxytryptamine Receptor Agonist market was valued at 5066 million in 2025 and is projected to reach US$ 7072 million by 2032, at a CAGR of 4.6% during the forecast period.

The global Lateral Flow Assay (LFA) market was valued at 12862 million in 2025 and is projected to reach US$ 22630 million by 2032, at a CAGR of 8.4% during the forecast period.

The global Equilibrium Dialysis market was valued at 185 million in 2025 and is projected to reach US$ 254 million by 2032, at a CAGR of 3.9% during the forecast period.

The global Trimodal Prostate Cancer Targeting Nanoparticle Imaging Agent market was valued at 68.63 million in 2025 and is projected to reach US$ 467 million by 2032, at a CAGR of 27.3% during the forecast period.

The global Humanized Mice Model market was valued at 130 million in 2025 and is projected to reach US$ 190 million by 2032, at a CAGR of 5.5% during the forecast period.

The global AI-assisted Diagnostic Software market was valued at 1713 million in 2025 and is projected to reach US$ 4144 million by 2032, at a CAGR of 13.4% during the forecast period.

The global Long-acting Growth Hormone Fusion Protein market was valued at 105 million in 2025 and is projected to reach US$ 623 million by 2032, at a CAGR of 22.2% during the forecast period.

The global AI Stroke Detection Software market was valued at 285 million in 2025 and is projected to reach US$ 1123 million by 2032, at a CAGR of 20.2% during the forecast period.

The global Pruritus Therapeutics market was valued at 12346 million in 2025 and is projected to reach US$ 16418 million by 2032, at a CAGR of 4.4% during the forecast period.

The global TCR-engineered T Cell Therapy market was valued at 559 million in 2025 and is projected to reach US$ 2899 million by 2032, at a CAGR of 26.3% during the forecast period.